drugset / Trial / NCT00716521

Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers

NCT00716521

Phase 1 Completed 11 enrolled Pfizer
RandomizedCrossoverSingle-blindBasic science

Summary

This study will assess the feasibility of conducting sleep studies in a clinical research unit environment. In addition, the sensitivity of polysomnography and mobile actigraphy technologies will be compared for evaluating sleep stages and sleep architecture.

Timeline

Start
2008-07
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule 5 mg Oral
Subject Zolpidem Small molecule 10 mg Oral

Indications

No indication recorded.